IL10 and melanoma: Additionally, miR-128 inhibits the p38 Mitogen-activated protein kinase (MAPK) signaling pathway, which reduces the production of interleukin (IL) 10 (IL-10) and IL-6 and, on the other hand, increases the formation of IL-12 in dendritic cells (DCs) and enhances DC antitumor immunity and the progression Reduces cancer in melanoma (22).